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Abstract
Background: Double aneuploidies - especially in combination with structural aberrations - are extremely rare
among liveborns. The most frequent association is that of Down (DS) and Klinefelter syndromes (KS). We present
the case of a male newborn with a unique 47,XY,+ 21[80%]/48,XY,+i(X)(q10),+ 21[20%] karyotype, hypothesize about
his future phenotype, discuss the aspects of management and review the literature.
Case presentation: The additional association of isochromosome Xq (i(X)(q10)) could be the result of a threefold
non-disjunction event. 47,XY,+i(X)(q10) KS is not common and its symptoms differ from the classical KS phenotype.
In combined DS and i(X)(q10) KS, the anticipatory phenotype is not simply the sum of the individual syndromic
characteristics. This genotype is associated with higher risk for several diseases and certain conditions with more
pronounced appearance: emotional and behavioral disorders; poorer mental and physical quality of life; lower
muscle mass/tone/strength; connective tissue weakness; muscle hypotonia and feeding difficulties; osteopenia/
−porosis with earlier beginning and faster progression; different types of congenital heart diseases; more common
occurrence of hypertension; increased susceptibility to infections and female predominant autoimmune diseases;
higher risk for hematological malignancies and testicular tumors.
Conclusions: In multiple aneuploidies, the alterations have the potential to weaken or enhance each other, or they
may not have modifying effects at all. Prenatal ultrasound signs are not obligatory symptoms of numerous
chromosomal anomalies (specifically those involving supernumerary sex chromosomes), therefore combined
prenatal screening has pertinence in uncomplicated pregnancies as well.
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Background
Double aneuploidies - especially in combination with
structural aberrations - are extremely rare among
liveborns. The most frequent co-occurrence is of Down
(DS) and Klinefelter syndromes (KS) (coincidence
0.098%) [1], because they are common and relatively
well tolerated chromosome abnormalities in humans [2].
Although their features are separately well described,
their co-occurrence and association with i(X)(q10) struc-
tural abnormality needs a specific approach.
Case presentation
The 2nd child of a healthy, non-consanguineous Caucasian
couple (31-year-old mother, 43-year-old father) was first re-
ferred to genetic counseling as a male newborn exclusively
with signs and symptoms of DS: flat occiput, small and
low-set ears, epicanthal folds, upslanting palpebral fissures,
rectus diasthasis, umbilical hernia, cutis marmorata, sandal
gaps on feet, moderate appetite and feeding difficulties
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because of generalized muscle hypotonia and a rela-
tively large tongue. During the event-free pregnancy
none of the prenatal ultrasound examinations showed
any abnormalities. The child was born naturally at 39
gestational weeks with 3170 g, 54 cm, 9/10 Apgar scores
and his postnatal adaptation was uneventful. Family his-
tory was negative for genetic diseases and developmental
disorders and no teratogenic damage was reported. Post-
natal analysis of his 15 Giemsa-stained metaphases from
standard 72-h peripheral blood lymphocyte cultures led to
the 47,XY,+ 21[80%]/48,XY,+i(X)(q10),+ 21[20%] geno-
type. The proportion of mosaicism was confirmed to be
47,XY,+ 21[80%]/48,XY,+i(X)(q10),+ 21[20%] by fluores-
cent in situ hybridization (FISH) of 200 interphase cells
with 21q22 region (Kreatech, Amsterdam, Netherlands),
Xp and Xq (Cytocell, United Kingdom) specific probes
(Fig. 1). The 2-month-old child was re-examined when
the genetic test results were reported. The features of DS
continued to dominate his phenotype, but due to his
young age we could not see any KS traits.
Discussion and conclusions
Incidence, etiology
Approximately 15% of clinically proven pregnancies end
with spontaneous miscarriages, half of them (7.5%) arise
from chromosome abnormalities. In the case of stillbirths
this rate is 6–13% [3]. In spontaneous abortions the detec-
tion rate of double and multiple aneuploidies is 4.6 and
0.4%, respectively. Double aneuploidies are mostly com-
posed (in descending frequency-order) of chromosome
21, 16, X, 22, 18, 13 and 15. The most frequent combina-
tions are -X/+ 21 (8.5%), + 21/+ 22 (4.4%), + 16/+ 21
(4.4%), + 7/+ 16 (4.4%) in double, and + X/+ 5/+ 8, + 8/+
20/+ 22, + 16/+ 20/+ 22, + 14/+ 21/+ 22, −X/+ 21/+ 21,
−X/+ 7/+ 21 in multiple aneuploidies. These results sug-
gest that the excess of chromosomes (with the exception
of X) is less tolerated than their deficiency. The incidence
of these abnormalities is significantly higher (59.2%) in
maternal age group 40–44 years [4], where the higher risk
of chromosome aberrations - due to the increased age
(≥35 years) - combines with greater willingness to bear
children in more developed countries.
The incidences of various chromosome aneuploidies
differ between livebirths and spontaneous abortions or
stillbirths. While autosomal trisomies in combination with
X monosomy are more common in the latter group, the as-
sociation of DS and KS are more dominant in the former
(incidence 4–9:100000 male newborns) [2]. Co-occurrence
of DS and KS is higher (9.8 × 10− 2) than expected (1.298 ×
10− 6) [1] because of their similar origin: increased predis-
position for non-disjunction events [5]. This hypothesis is
supported by the theory that the imbalance of one chromo-
some increases the risk for further aberrations [6, 7]. The
simultaneous appearance of our patient’s three chromo-
somal aberrations is therefore the result of a threefold non-
disjunction event.
Cumulative cell division defects may be explainable by
the presence of different epigenetic and other risk fac-
tors. The risk is higher in instances of increased mater-
nal (≥35 years) or paternal (≥45 years) age [8], cousin
marriage, known genetic disorders in the family, patho-
logical fetal ultrasound signs, increased maternal serum
marker levels, quantitative abnormalities of amniotic
fluid, certain medicaments, infections, chemicals or ion-
izing radiation during the pregnancy.
88% of DS cases arise from the 2nd maternal and the
1st grandmaternal meiotic cell division, 8% have paternal
origin and 4% occur after fertilization [9, 10]. Meiotic
non-disjunction events causing KS are inherited mater-
nally in 50–56% of cases (36% occur in 1st and 20% in
2nd meiosis), and paternally in 44–50% (100% 1st mei-
osis) [11, 12]. Isochromosome Xq originates presumably
during the 2nd maternal meiosis from a separation error
of the centromere or the sister chromatids [12].
In the presented newborn the excess of chromosome
21, as it is non-mosaic, could have originated from either
a paternal or maternal germ cell, or from an early post-
zygotic cell division defect. In contrast, the i(X)(q10) is
not present in all the lymphocytes of the patient. Some
Fig. 1 The presented patient’s genotype: 47,XY,+21[80%]/
48,XY,+i(X)(q10),+21[20%]. a Partial karyogram with Giemsa-banding
b FISH image of a metaphase cell with three 21q22 region signals
(short red arrows), three Xq arm signals (short green arrows) and
one Xp arm signal (long red arrow)
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authors suggest that 47,XY,+i(X)(q10) could be maternally
inherited [12], but on the basis of mosaicism a postzygotic,
mitotic defect is more likely in the present case. A further
explanation could be that the maternally inherited extra
chromosome had been lost during somatic cell divisions
as the result of a negative selection effect.
Genotype-phenotype correlation (Table 1)
Down syndrome
The immune system’s dysregulation and its consequences,
as well as the higher risk for infections and some types of
leukemias are characteristic for DS [13, 14]. A further,
scarcely understood aspect is that patients with DS have
decreased risk for certain solid tumors, a notable excep-
tion being testicular cancer [15]. This relative protection
could be explained by higher dosages of putative tumor
suppressor loci on chromosome 21 [16, 17].
Children with DS have a 20-fold greater risk for acute
lymphoid leukemia (ALL) and a 500-fold higher risk for
myeloid leukemia (ML) compared to children without DS.
Overall survival (OS) in DS-ALL (70%) is below the group
of patients without DS (OS: 89%). The increased rate of
treatment-related toxicity and infectious deaths in DS-
ALL can be explained by the patients’ altered metabolic
profile and immunodeficient state. The long-distance out-
comes are further worsened by the high risk for relapse
even after hematopoietic stem cell transplantation. Min-
imal residual disease response can differentiate between
low and high relapse risk DS-ALL patients, and indicate
the necessary and safe intensity of treatment [18].
5–10% of DS newborns have manifest, and 10–31% have
silent transient myeloproliferative disorder (TMD). TMD is
a preleukemia characterised by GATA Binding Protein 1
(GATA1) gene mutations in 30% of DS newborns. 25% of
TMD in DS (DS-TMD) undergo spontaneous regression
(in the first 3months of life), while the remainder will go
on to develop myeloid leukemia of DS (ML-DS). Most
cases of DS-TMD are diagnosed 3–7 days after birth, but
almost all of them present signs of TMD by age 2months.
20–30% of TMD (meaning 0.5–2% of all patients with DS)
will go on to develop ML-DS (within the first 2–4 years of
life, approximately 1.2–1.5 years from the onset of TMD)
or, less commonly, ALL. ML-DS involves two entities: mye-
lodysplastic syndrome (MDS) and acute megakaryoblastic
leukemia (AMKL). MDS often precedes AMKL [18].
There is no standard for screening GATA1 mutations
in patients with DS, but international guidelines recom-
mend at least one full blood count (FBC) for newborns.
Patients who have documented DS-TMD require regular
monitoring every 3 months until 4 years of age with FBC
and physical examination, due to their higher risk for
developing ML-DS. ML-DS patients have significantly
better disease-free survival (DFS: 88–89%) compared to
children without DS (DFS: 42%), because ML-DS shows
better response to less intense therapy. The better che-
mosensitivity of AMKL could be explained by alteration
of cytarabine metabolism. Patients with DS – who de-
velop AMKL – have better 5-years event-free survival
(5yEFS: 81%) under the age of 4 years than older chil-
dren (5yEFS: 33%). Children over 4 years of age with DS
and AMKL are more likely to have cytogenetic aberra-
tions similar to sporadic AML, therefore older children
with AMKL need more intense therapy [18].
Klinefelter syndrome
47,XY,+i(X)(q10) is very rare among patients with KS.
Including our patient, 23 cases have been reported so
far. Although the KS encompasses a wide spectrum of
features, the classical phenotype includes consequences
of hypergonadotropic hypogonadism. Height can exceed
the average, presumably because of delayed epiphyseal
plate closure and the extra copy of short stature homeo-
box (SHOX) gene on Xp [19–23].
Several studies have dealt with the distinct phenotypic
effect of the supernumerary X chromosome in KS. It has
emerged that the X inactivation pattern of KS patients is
similar to that of healthy women, which extends not
only to the extra X chromosome(s), but also to the auto-
somes. Protection against inactivation is ensured by the
expression of X inactive specific transcript (XIST) gene
on the long arm of the active X. This mechanism regu-
lates X-chromosomal gene dosages in relation to the
number of autosomes, therefore in cases of tri-, tetra- or
higher polyploidy, there are more than one active X
chromosomes [24]. Therefore, the KS phenotype is influ-
enced by more than simply the increased dosages of
non-inactivated X-chromosomal genes [7, 23]. In KS pa-
tients this may lead to the increased incidence of female
predominant autoimmune disorders [25].
Skakkebæk et al. analysed the genome-wide transcrip-
tome and methylome of peripheral blood leukocytes in
KS patients, male and female controls and detected a
unique, KS-specific genetic and epigenetic landscape.
They identified candidate genes (coding and non-
coding) and regions responsible for the diverse KS fea-
tures and comorbidities [23].
I(X)(q10) Klinefelter syndrome
In 47,XY,+i(X)(q10) some traits, but not all, could easily
be originated from the altered dosages of the X chromo-
somal arms. The excess of Xq is responsible for most of
the typical KS symptoms, and the relative lack of Xp for
normal height and intellect [7, 20].
The frequency of various autoimmune diseases distrib-
utes differently between the sexes and different types of
chromosome abnormalities, which illustrates the dosage-
dependent effect of X-chromosomal genes. Approximately
15% of them remain active (30% of the Xp and < 3% of the
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Xq genes) [26]. More precisely, 5% of the genes escape
completely from inactivation and 10% show variable cell-
type specific patterns [7]. Decreased expression of Forkhead
Box P3 (FOXP3) gene on Xp11.23, which encodes a tran-
scription factor responsible for regulatory T-cell differenti-
ation, leads to insufficient inhibition of autoreactive T-cells.
Deletion of FOXP3 causes the IPEX syndrome, which is
characterized by immune-dysregulation, polyendocrinopa-
thy, enteropathy and X-linked inheritance. Further anti-
(Interleukin 10 (IL10), Transforming Growth Factor Beta 2
(TGFβ2)) and pro-inflammatory (Interleukin 6 (IL6), Trans-
forming Growth Factor Beta 1 (TGFβ1)) cytokine genes are
located on the X chromosome, altered dosages of which in-
fluence the immune system’s regulation in the opposite
way. The decreased dosages of anti-inflammatory cytokine
genes on Xp and the increased copies of pro-inflammatory
cytokine genes on Xq lead to higher risk for autoimmune
diseases. This data is supported by the fact that some disor-
ders (e.g. Hashimoto’s disease) occur more commonly
among patients with 45,X,i(X)(q10) Turner syndrome [27].
A similar relationship between the altered cytokine gene
dosages and higher autoimmune disease risk may exist in
KS with i(X)(q10) structural abnormality.
It is not yet known how inactivation is affected in struc-
tural X abnormalities, notably in the 47,XY,+i(X)(q10)
genotype. Considering the results of Skakkebæk et al., the
expression of candidate Xp genes presumably involved in
the KS phenotype may not be altered in the case of
i(X)(q10) KS, therefore those features should be lacking.
One of those genes is eukaryotic translation initiation fac-
tor 2 subunit gamma (EIF2S3), which is associated with
diabetes, cognitive dysfunction and altered brain volumes,
hypogonadism and azoospermia in typical KS [23]. If the
expression of EIF2S3 is not altered in i(X)(q10) KS, the
aforementioned symptoms should be not present. This
hypothesis is supported by the fact that as of yet all re-
ported i(X)(q10) KS patients have normal intellect. On the
other hand, these patients are affected by hypogonadism
and azoospermia, which further complicates the proper
understanding of genotype-phenotype correlations.
Double 48,XXY,+ 21 trisomy
Since the first description of double 48,XXY,+ 21 trisomy
[28], 82 postnatal and 17 prenatal cases have been reported
[29]. Interestingly, in 1963 Wright and his colleagues re-
ported two independent sibling duos with single aneu-
ploidies. There was one child with KS and one with DS in
each family [30], which are further examples of the com-
mon combination of these aneuploidies and the increased
predisposition for non-disjunction events. Prenatal hints of
similar cases could be the ultrasound signs of DS and the
increased maternal serum marker levels. Keeping in mind
that ultrasound signs are not obligatory, simultaneous
screening of biomarker levels is essential. Prenatal
ultrasound examinations of the presented patient did not
show any pathological alterations. Since the mother was
under 35 years of age, no serum biomarker testing was con-
ducted. Our patient’s case supports the relevance of com-
bined prenatal testing in uncomplicated pregnancies.
In cases of combined DS and KS the incidence of con-
genital heart disease could be higher compared to the
isolated forms of these aneuploidies. In 12 previously de-
scribed 48,XXY,+ 21 cases atrial and atrioventricular
septal defects were the most frequent abnormalities [31].
In addition, the spectrum of different mental problems
could be wider, and their risk could be higher in this
group of patients.
The phenotype of 48,XXY,+ 21 double aneuploidy is
characterized by classical DS features in children, who
then develop additional KS symptoms from the age of
puberty. If we experience the following symptoms, we
should suspect the presence of KS beside DS: male in-
fant with developmental abnormalities of the genitalia
(hypospadias, micropenis, cryptorchidism), delay or ab-
sence of puberty, signs of hypergonadotropic hypo-
gonadism (absence of voice cracking, female secondary
sex characteristics, gynecomastia, < 4 ml testicle volume),
oligo−/azoospermia, tall stature (>97th percentile).
Combined Down and i(X)(q10) Klinefelter syndrome
The combined DS and i(X)(q10) KS is associated with
higher risk for several diseases and certain conditions with
more pronounced appearance: emotional and behavioral
disorders; poorer mental and physical quality of life; lower
muscle mass/tone/strength; connective tissue weakness;
muscle hypotonia and feeding difficulties; osteopenia/−poro-
sis with earlier beginning and faster progression; different
types of congenital heart diseases; more common occur-
rence of hypertension; increased susceptibility to infections
and female predominant autoimmune diseases; higher risk
for hematological malignancies and testicular tumors.
In multiple aneuploidies and compound chromosomal
abnormalities the anticipatory phenotype is not simply the
sum of the individual syndromic characteristics. The alter-
ations have the potential to weaken or enhance each other,
or they may not have modifying effects at all. Prenatal ultra-
sound signs are not obligatory symptoms of numerous
chromosomal anomalies (specifically those involving super-
numerary sex chromosomes), therefore combined prenatal
screening has pertinence in uncomplicated pregnancies as
well. This might also suggest that only chromosomal anom-
alies that usually lead to pronounced anatomical malforma-
tions (e.g. 21/13/18 trisomies) may be detected during the
18- to 22-week fetal anatomical ultrasound. In cases of
i(X)(q10) KS long-term follow-up, transcriptome and
methylome analyses are needed to clarify the role of the X-
chromosomal regions in KS traits, the regulation of the im-
mune system and autoimmune diseases.
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